Indegene has received approval from Board of Directors for investment in equity shares of Indegene Ireland, a wholly owned subsidiary of the Company, up to an amount of Euro 8.5 million, in one or more tranches. This investment in Indegene Ireland is to support the Subsidiary with capex requirement intended to expand its business.
The Board of Directors of Indegene at its meeting held on October 30, 2025, has approved the same. The said investment will be completed by December 31, 2026.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 404.75 |
| Indegene | 490.05 |
| CMS Info Systems | 298.60 |
| JITF Infralogistics | 333.50 |
| Sagility | 42.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: